Mayo clinic study aims to define normal vaccine reactions in kids
NCT ID NCT04112355
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study from Mayo Clinic measures how healthy children's immune systems respond to routine vaccines. Researchers will take blood samples before and after vaccination to track levels of various immune markers. The goal is to establish a range of normal responses, which could help identify when a child's immune system is not working properly. The study will also look at whether certain genetic differences affect these responses.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- This study could help doctors better understand what a normal immune response to vaccines looks like in healthy children, which may improve care for kids with unusual reactions to infections.
- What could go wrong
- This is an observational study, not a treatment trial. It only measures responses in healthy children, so results may not apply to sick children or lead to direct medical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY CONTROLS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mining mountains of data to outsmart diabetes complications
- Psilocybin without the trip: scientists hunt for a microdose that skips hallucinations
- Manitoba DNA hunt could revolutionize schizophrenia care
- Brain insulin study aims to uncover why antipsychotics cause weight gain
- Ketone drink may boost brain fuel in prediabetes
- Experimental drug VVZ-2471 gets first safety check in humans